Standard Biotools (LAB) Divestments (2026)
Standard Biotools' (LAB) quarterly Divestments came in at $363.2 million in Q1 2026.
Standard Biotools (LAB) Divestments (2026) Analysis & Trends
Standard Biotools (LAB) has 1 years of Divestments data on file, last reported at $363.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 9.37 Mn |
| 10 | Standard Biotools | 309.82 Mn | -145.35 Mn | 11.31 Mn | 363.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 363.22 Mn |